{"id":509040,"date":"2021-07-01T16:04:07","date_gmt":"2021-07-01T20:04:07","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/prestige-consumer-healthcare-completes-acquisition-of-theratears-announces-first-quarter-fiscal-2022-earnings-results-date\/"},"modified":"2021-07-01T16:04:07","modified_gmt":"2021-07-01T20:04:07","slug":"prestige-consumer-healthcare-completes-acquisition-of-theratears-announces-first-quarter-fiscal-2022-earnings-results-date","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/prestige-consumer-healthcare-completes-acquisition-of-theratears-announces-first-quarter-fiscal-2022-earnings-results-date\/","title":{"rendered":"Prestige Consumer Healthcare Completes Acquisition of TheraTears, Announces First Quarter Fiscal 2022 Earnings Results Date"},"content":{"rendered":"
\n

TARRYTOWN, N.Y., July 01, 2021 (GLOBE NEWSWIRE) — Prestige Consumer Healthcare Inc.\u00a0(NYSE:PBH) (\u201cPrestige\u201c or the \u201cCompany\u201d) today announced that it has completed the previously announced acquisition of\u00a0TheraTears and other over-the-counter consumer brands.\u00a0\u00a0 The closing was finalized pursuant to the terms of the asset purchase agreement which was initially announced on\u00a0May 27, 2021, under which Prestige agreed to acquire the brands from specialty pharmaceutical company,\u00a0Akorn Operating Company LLC\u00a0(\u201cAkorn\u201d), for\u00a0$230 million\u00a0in cash. The acquisition of TheraTears will further enhance Prestige\u2019s leading eye care portfolio and generate additional long-term growth opportunities for the Company.<\/p>\n

The acquisition is structured as an asset purchase that delivers anticipated tax benefits of\u00a0~$30 million\u00a0and expected annual EBITDA of\u00a0~$20 million,\u00a0equating to a transaction valued at less than 10x pro-forma EBITDA. The transaction is estimated to add annual Revenues, Earnings Per Share and Operating Cash Flow of approximately\u00a0$60 million,\u00a0$0.10\u00a0and\u00a0$13 million, respectively.<\/p>\n

The Company financed the transaction with a combination of available cash on hand, available cash from its Asset Based Loan (\u201cABL\u201d) revolver, and a simultaneously completed refinancing of its term loan, which now matures in 2028 and amends and replaces Prestige\u2019s previous outstanding term loan at similar terms.<\/p>\n

\n Earnings Results Conference Call Details<\/strong>\n <\/p>\n

The Company also announced that it will issue its fiscal 2022 first quarter earnings release on\u00a0Thursday, August 5, 2021\u00a0before the opening of the market. The Company will host a conference call to discuss the results that same morning at\u00a08:30 a.m. ET.<\/p>\n

To participate via phone listeners calling from the\u00a0U.S.\u00a0and\u00a0Canada\u00a0may dial 844-233-9440, or 574-990-1016 internationally, using the conference ID 5362477. The Company will provide a live Internet webcast as well as an archived replay, which can be accessed from the Investor Relations page of\u00a0www.prestigeconsumerhealthcare.com<\/strong><\/a>.<\/p>\n

Telephonic replays will be available for approximately one week following completion of the live call and can be accessed at 855-859-2056 within\u00a0North America, and at 404-537-3406 from outside\u00a0North America. The conference ID is 5362477.<\/p>\n

\n About\u00a0Prestige Consumer Healthcare Inc.<\/strong>
\n
Prestige Consumer Healthcare\u00a0markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the\u00a0U.S.\u00a0and\u00a0Canada,\u00a0Australia, and in certain other international markets. The Company\u2019s diverse portfolio of brands include Monistat\u00ae<\/sup>\u00a0and Summer\u2019s Eve\u00ae<\/sup>\u00a0women’s health products, BC\u00ae<\/sup>\u00a0and Goody’s\u00ae<\/sup>\u00a0pain relievers, Clear Eyes\u00ae<\/sup>\u00a0and TheraTears\u00ae<\/sup>\u00a0eye care products, DenTek\u00ae<\/sup>\u00a0specialty oral care products, Dramamine\u00ae<\/sup>\u00a0motion sickness treatments, Fleet\u00ae<\/sup>\u00a0enemas and glycerin suppositories, Chloraseptic\u00ae<\/sup>\u00a0and Luden’s\u00ae<\/sup>\u00a0sore throat treatments and drops, Compound W\u00ae<\/sup>\u00a0wart treatments, Little Remedies\u00ae<\/sup>\u00a0pediatric over-the-counter products, Boudreaux\u2019s Butt Paste\u00ae<\/sup>\u00a0diaper rash ointments, Nix\u00ae<\/sup>\u00a0lice treatment, Debrox\u00ae<\/sup>\u00a0earwax remover, Gaviscon\u00ae<\/sup>\u00a0antacid in\u00a0Canada, and Hydralyte\u00ae<\/sup>\u00a0rehydration products and the Fess\u00ae<\/sup>\u00a0line of nasal and sinus care products in\u00a0Australia. Visit the Company’s website at\u00a0www.prestigeconsumerhealthcare.com<\/strong><\/a>.<\/p>\n

Investor Relations Contact
Phil Terpolilli, CFA, 914-524-6819
irinquiries@prestigebrands.com<\/strong><\/a><\/p>\n

\n
\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

TARRYTOWN, N.Y., July 01, 2021 (GLOBE NEWSWIRE) — Prestige Consumer Healthcare Inc.\u00a0(NYSE:PBH) (\u201cPrestige\u201c or the \u201cCompany\u201d) today announced that it has completed the previously announced acquisition of\u00a0TheraTears and other over-the-counter consumer brands.\u00a0\u00a0 The closing was finalized pursuant to the terms of the asset purchase agreement which was initially announced on\u00a0May 27, 2021, under which Prestige agreed to acquire the brands from specialty pharmaceutical company,\u00a0Akorn Operating Company LLC\u00a0(\u201cAkorn\u201d), for\u00a0$230 million\u00a0in cash. The acquisition of TheraTears will further enhance Prestige\u2019s leading eye care portfolio and generate additional long-term growth opportunities for the Company. The acquisition is structured as an asset purchase that delivers anticipated tax benefits of\u00a0~$30 million\u00a0and expected annual EBITDA of\u00a0~$20 million,\u00a0equating to a transaction valued at less than 10x pro-forma … <\/p>\n

Continue reading “Prestige Consumer Healthcare Completes Acquisition of TheraTears, Announces First Quarter Fiscal 2022 Earnings Results Date”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-509040","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nPrestige Consumer Healthcare Completes Acquisition of TheraTears, Announces First Quarter Fiscal 2022 Earnings Results Date - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/prestige-consumer-healthcare-completes-acquisition-of-theratears-announces-first-quarter-fiscal-2022-earnings-results-date\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Prestige Consumer Healthcare Completes Acquisition of TheraTears, Announces First Quarter Fiscal 2022 Earnings Results Date - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"TARRYTOWN, N.Y., July 01, 2021 (GLOBE NEWSWIRE) — Prestige Consumer Healthcare Inc.\u00a0(NYSE:PBH) (\u201cPrestige\u201c or the \u201cCompany\u201d) today announced that it has completed the previously announced acquisition of\u00a0TheraTears and other over-the-counter consumer brands.\u00a0\u00a0 The closing was finalized pursuant to the terms of the asset purchase agreement which was initially announced on\u00a0May 27, 2021, under which Prestige agreed to acquire the brands from specialty pharmaceutical company,\u00a0Akorn Operating Company LLC\u00a0(\u201cAkorn\u201d), for\u00a0$230 million\u00a0in cash. The acquisition of TheraTears will further enhance Prestige\u2019s leading eye care portfolio and generate additional long-term growth opportunities for the Company. The acquisition is structured as an asset purchase that delivers anticipated tax benefits of\u00a0~$30 million\u00a0and expected annual EBITDA of\u00a0~$20 million,\u00a0equating to a transaction valued at less than 10x pro-forma … Continue reading "Prestige Consumer Healthcare Completes Acquisition of TheraTears, Announces First Quarter Fiscal 2022 Earnings Results Date"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/prestige-consumer-healthcare-completes-acquisition-of-theratears-announces-first-quarter-fiscal-2022-earnings-results-date\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-01T20:04:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NDIwNyM0Mjc5NTc4IzIwMDk2MTk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prestige-consumer-healthcare-completes-acquisition-of-theratears-announces-first-quarter-fiscal-2022-earnings-results-date\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prestige-consumer-healthcare-completes-acquisition-of-theratears-announces-first-quarter-fiscal-2022-earnings-results-date\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Prestige Consumer Healthcare Completes Acquisition of TheraTears, Announces First Quarter Fiscal 2022 Earnings Results Date\",\"datePublished\":\"2021-07-01T20:04:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prestige-consumer-healthcare-completes-acquisition-of-theratears-announces-first-quarter-fiscal-2022-earnings-results-date\\\/\"},\"wordCount\":487,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prestige-consumer-healthcare-completes-acquisition-of-theratears-announces-first-quarter-fiscal-2022-earnings-results-date\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3NDIwNyM0Mjc5NTc4IzIwMDk2MTk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prestige-consumer-healthcare-completes-acquisition-of-theratears-announces-first-quarter-fiscal-2022-earnings-results-date\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prestige-consumer-healthcare-completes-acquisition-of-theratears-announces-first-quarter-fiscal-2022-earnings-results-date\\\/\",\"name\":\"Prestige Consumer Healthcare Completes Acquisition of TheraTears, Announces First Quarter Fiscal 2022 Earnings Results Date - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prestige-consumer-healthcare-completes-acquisition-of-theratears-announces-first-quarter-fiscal-2022-earnings-results-date\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prestige-consumer-healthcare-completes-acquisition-of-theratears-announces-first-quarter-fiscal-2022-earnings-results-date\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3NDIwNyM0Mjc5NTc4IzIwMDk2MTk=\",\"datePublished\":\"2021-07-01T20:04:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prestige-consumer-healthcare-completes-acquisition-of-theratears-announces-first-quarter-fiscal-2022-earnings-results-date\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prestige-consumer-healthcare-completes-acquisition-of-theratears-announces-first-quarter-fiscal-2022-earnings-results-date\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prestige-consumer-healthcare-completes-acquisition-of-theratears-announces-first-quarter-fiscal-2022-earnings-results-date\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3NDIwNyM0Mjc5NTc4IzIwMDk2MTk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3NDIwNyM0Mjc5NTc4IzIwMDk2MTk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prestige-consumer-healthcare-completes-acquisition-of-theratears-announces-first-quarter-fiscal-2022-earnings-results-date\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Prestige Consumer Healthcare Completes Acquisition of TheraTears, Announces First Quarter Fiscal 2022 Earnings Results Date\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Prestige Consumer Healthcare Completes Acquisition of TheraTears, Announces First Quarter Fiscal 2022 Earnings Results Date - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/prestige-consumer-healthcare-completes-acquisition-of-theratears-announces-first-quarter-fiscal-2022-earnings-results-date\/","og_locale":"en_US","og_type":"article","og_title":"Prestige Consumer Healthcare Completes Acquisition of TheraTears, Announces First Quarter Fiscal 2022 Earnings Results Date - Market Newsdesk","og_description":"TARRYTOWN, N.Y., July 01, 2021 (GLOBE NEWSWIRE) — Prestige Consumer Healthcare Inc.\u00a0(NYSE:PBH) (\u201cPrestige\u201c or the \u201cCompany\u201d) today announced that it has completed the previously announced acquisition of\u00a0TheraTears and other over-the-counter consumer brands.\u00a0\u00a0 The closing was finalized pursuant to the terms of the asset purchase agreement which was initially announced on\u00a0May 27, 2021, under which Prestige agreed to acquire the brands from specialty pharmaceutical company,\u00a0Akorn Operating Company LLC\u00a0(\u201cAkorn\u201d), for\u00a0$230 million\u00a0in cash. The acquisition of TheraTears will further enhance Prestige\u2019s leading eye care portfolio and generate additional long-term growth opportunities for the Company. The acquisition is structured as an asset purchase that delivers anticipated tax benefits of\u00a0~$30 million\u00a0and expected annual EBITDA of\u00a0~$20 million,\u00a0equating to a transaction valued at less than 10x pro-forma … Continue reading \"Prestige Consumer Healthcare Completes Acquisition of TheraTears, Announces First Quarter Fiscal 2022 Earnings Results Date\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/prestige-consumer-healthcare-completes-acquisition-of-theratears-announces-first-quarter-fiscal-2022-earnings-results-date\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-01T20:04:07+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NDIwNyM0Mjc5NTc4IzIwMDk2MTk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prestige-consumer-healthcare-completes-acquisition-of-theratears-announces-first-quarter-fiscal-2022-earnings-results-date\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prestige-consumer-healthcare-completes-acquisition-of-theratears-announces-first-quarter-fiscal-2022-earnings-results-date\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Prestige Consumer Healthcare Completes Acquisition of TheraTears, Announces First Quarter Fiscal 2022 Earnings Results Date","datePublished":"2021-07-01T20:04:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prestige-consumer-healthcare-completes-acquisition-of-theratears-announces-first-quarter-fiscal-2022-earnings-results-date\/"},"wordCount":487,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prestige-consumer-healthcare-completes-acquisition-of-theratears-announces-first-quarter-fiscal-2022-earnings-results-date\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NDIwNyM0Mjc5NTc4IzIwMDk2MTk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prestige-consumer-healthcare-completes-acquisition-of-theratears-announces-first-quarter-fiscal-2022-earnings-results-date\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/prestige-consumer-healthcare-completes-acquisition-of-theratears-announces-first-quarter-fiscal-2022-earnings-results-date\/","name":"Prestige Consumer Healthcare Completes Acquisition of TheraTears, Announces First Quarter Fiscal 2022 Earnings Results Date - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prestige-consumer-healthcare-completes-acquisition-of-theratears-announces-first-quarter-fiscal-2022-earnings-results-date\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prestige-consumer-healthcare-completes-acquisition-of-theratears-announces-first-quarter-fiscal-2022-earnings-results-date\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NDIwNyM0Mjc5NTc4IzIwMDk2MTk=","datePublished":"2021-07-01T20:04:07+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prestige-consumer-healthcare-completes-acquisition-of-theratears-announces-first-quarter-fiscal-2022-earnings-results-date\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/prestige-consumer-healthcare-completes-acquisition-of-theratears-announces-first-quarter-fiscal-2022-earnings-results-date\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prestige-consumer-healthcare-completes-acquisition-of-theratears-announces-first-quarter-fiscal-2022-earnings-results-date\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NDIwNyM0Mjc5NTc4IzIwMDk2MTk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NDIwNyM0Mjc5NTc4IzIwMDk2MTk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prestige-consumer-healthcare-completes-acquisition-of-theratears-announces-first-quarter-fiscal-2022-earnings-results-date\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Prestige Consumer Healthcare Completes Acquisition of TheraTears, Announces First Quarter Fiscal 2022 Earnings Results Date"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/509040","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=509040"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/509040\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=509040"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=509040"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=509040"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}